Prenatal Healthcare

Prenatal Genetic tests optimised and validated using plasma & cffDNA

A range of non-invasive prenatal products to allow sensitive and accurate detection of
fetal specific genetic conditions.

Non-invasive prenatal healthcare

Prenatal genetic testing currently requires an amniocentesis or CVS, both invasive procedures that carry a level of risk to the foetus. However, the cell-free foetal DNA (cffDNA) released into maternal blood during pregnancy, offers an alternative method of detecting foetal genotypes that is less invasive and poses no risk to the foetus.  A simple blood test.

The detection of cffDNA from a maternal blood sample can be challenging though as it is present in very low quantities and requires extremely sensitive and accurate assays to be confident in results. Nonacus have developed two proprietary technologies, Cell3™ Direct (direct from plasma real-time PCR) and Cell3™ Target (exquisitely sensitive targeted NGS libraries), to provide your laboratory with a range of products for all your prenatal testing needs.

Our Prenatal Products

See our range of prenatal products validated on plasma and cff DNA below.

Cell3™ Direct: Fetal RhD Genotyping

The first direct from plasma NIPD test for fetal RhD status

The first 'direct from plasma' non-invasive prenatal diagnosis kit for fetal Rhesus D (RhD) genotyping. With no cffDNA extraction required, Cell3™ Direct reduces cost and saves time in fetal Rhesus D diagnosis. Targeting sequences specific for exons 5, 7 and 10 of the RhD gene this kit can distinguish between RhD positive, negative and Psi genotypes in cffDNA.

Scientist placing clear liquid in an Eppendorf tube

Cell3™ Target: Custom NGS panels

Ultra sensitive NGS panels for prenatal genetics

Target the genes and variants important to your research by creating your own NGS panel using our ultra-sensitive Cell3 Target enrichment system. Suitable for pre-and postnatal genetic testing using cell-free foetal (cff) DNA, these targeted panels require as little as 10 ng DNA input and allow detection of heterozygous mutations down to 0.1% VAF.

Cell3 Target scientist in lab coat pointing at DNA molecule

Other Products for Prenatal Healthcare

Validated on amniocentesis and CVS samples. 

Cell3™ Target: Nexome

A clinically enhanced exome panel for detecting SNVs, indels and CNVs

An exome panel with enhanced coverage of clinically relevant regions that allows you to confidently call all variants (SNVs, indels and CNVs) in one clinical-grade assay increasing your diagnostic yield without increasing your sequencing costs.

Exome capture panel, Animated chromosome showing DNA molecule
Exome sequencing for cytogeneticists

Cell3™ Target: ExomeCG

No more arrays. Detect SNVs, indels and CNVs in a single test.

An exome enrichment augmented with baits to provide increased coverage of genes of clinical importance for both pre- and postnatal testing. Designed specifically for cytogenetic analysis this exome enrichment allows you to detect all variants (SNVs, indels and CNVs) in a single assay from as little as 10ng input.

Validated on amniocentesis and CVS samples without the need for any culturing. For singleton, duo or trio based analysis.

Are you ready to innovate your cfDNA capability?

Contact us for a quote.